Christina Y. Weng, MD, MBA, FASRS, highlights findings showing statin use reduced PVR risk by 25% in a propensity-matched ...

Steve Swalgen is national director of lab business, Santinelli International, Hauppauge, NY. Swalgen also is an advisory board member of the Optical Laboratory Association (OLA) and has developed and ...

At Retina Society 2026, Emily Eton, MD, discusses a 10-center study finding similar exudate control in Coats disease and ...

Subretinal drusenoid deposits (SDDs) in age-related macular degeneration may flag severe aortic stenosis that increases ...

Jesse L. Berry, MD, discusses prospective data on aqueous humor liquid biopsy in retinoblastoma and explains how molecular markers from the aqueous are beginning to guide recurrence risk, treatment ...

In this episode of The Retina TL;DR with Dr. Weng, powered by Modern Retina, host Christina Y. Weng, MD, MBA, FASRS, professor and the Alice R. McPherson Retina Research Foundatio ...

Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, ...

At Retina Society 2026, Eileen Hwang, MD, PhD, discusses a meta-analysis finding a 1.78 times higher retinal detachment rate ...

Concurrent exudative disease, early intervention, and a rare masquerader complicate the classic picture of geographic atrophy ...

Charles Wykoff, MD, PhD, reviews LUGANO safety and treatment burden data, including a 42% injection reduction with vorolanib ...

Patient enrollment is complete in the the ASTRA phase 3 study AURN001 to treat corneal edema associated with corneal ...

The alternative pathway ratios Ba/Factor B (0.350, 95% CrI: 0.021 to 0.644), and Bb/Factor B (0.203, 95% CrI: -0.086 to 0.475 ...